Oxford Nanopore Technologies Ltd (ONT) - Total Liabilities

Latest as of December 2025: GBX159.20 Million GBX ≈ $19.37K USD

Based on the latest financial reports, Oxford Nanopore Technologies Ltd (ONT) has total liabilities worth GBX159.20 Million GBX (≈ $19.37K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Oxford Nanopore Technologies Ltd to track the company's year-over-year net asset growth rate.

Oxford Nanopore Technologies Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Oxford Nanopore Technologies Ltd's total liabilities have evolved over time, based on quarterly financial data. See Oxford Nanopore Technologies Ltd (ONT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Oxford Nanopore Technologies Ltd Competitors by Total Liabilities

The table below lists competitors of Oxford Nanopore Technologies Ltd ranked by their total liabilities.

Company Country Total Liabilities
Obiz Concept SAS
PA:ALBIZ
France €42.26 Million
Rcm Beteiligungs AG
F:RCMN
Germany €28.48K
Vizione Holdings Bhd
KLSE:7070
Malaysia RM294.01 Million
Dantax
CO:DANT
Denmark Dkr5.84 Million
ValOre Metals Corp
V:VO
Canada CA$1.25 Million
Impact Minerals Ltd
AU:IPT
Australia AU$690.13K
Airthings ASA
OL:AIRX
Norway Nkr14.37 Million
Miwon Chemical
KO:134380
Korea ₩45.89 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Oxford Nanopore Technologies Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ONT market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.56 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.34 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Oxford Nanopore Technologies Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Oxford Nanopore Technologies Ltd (2012–2025)

The table below shows the annual total liabilities of Oxford Nanopore Technologies Ltd from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 GBX159.20 Million
≈ $19.37K
+2.24%
2024-12-31 GBX155.71 Million
≈ $18.95K
+16.89%
2023-12-31 GBX133.21 Million
≈ $16.21K
+2.21%
2022-12-31 GBX130.33 Million
≈ $15.86K
-5.48%
2021-12-31 GBX137.89 Million
≈ $16.78K
+44.73%
2020-12-31 GBX95.28 Million
≈ $11.59K
+72.58%
2019-12-31 GBX55.21 Million
≈ $6.72K
+70.95%
2018-12-31 GBX32.30 Million
≈ $3.93K
+25.55%
2017-12-31 GBX25.72 Million
≈ $3.13K
+87.69%
2016-12-31 GBX13.71 Million
≈ $1.67K
+65.34%
2015-12-31 GBX8.29 Million
≈ $1.01K
+93.62%
2014-12-31 GBX4.28 Million
≈ $520.87
+38.19%
2013-12-31 GBX3.10 Million
≈ $376.94
+54.29%
2012-12-31 GBX2.01 Million
≈ $244.30
--

About Oxford Nanopore Technologies Ltd

LSE:ONT UK Biotechnology
Market Cap
$13.84 Million
GBX113.78 Billion GBX
Market Cap Rank
#26201 Global
#305 in UK
Share Price
GBX117.00
Change (1 day)
+0.26%
52-Week Range
GBX104.50 - GBX219.00
All Time High
GBX716.00
About

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more